When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DARE - Daré Bioscience wins FDA approval for XACIATO antibacterial gel
Dare Bioscience Inc.
Daré Bioscience (DARE +10.5%) is trading sharply higher on the FDA approval of XACIATOTM (clindamycin phosphate) for the treatment of bacterial vaginosis in females aged 12 and above. In Q3 2021, the FDA had accepted the company’s marketing application for XACIATOTM with priority review. The regulator had set Dec. 07 as the PDUFA action date to complete its review. This is a developing story. Check back for more updates.